Skip to content

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

Tablet-Aided BehavioraL Intervention EffecT on Self-management Skills

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02128854
Acronym
TABLETS
Enrollment
60
Registered
2014-05-01
Start date
2014-08-14
Completion date
2016-08-31
Last updated
2017-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Noninsulin Dependent, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type II

Keywords

Diabetes Mellitus, Type 2, Diabetes Mellitus, Adult-Onset, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Noninsulin Dependent, Diabetes Mellitus, Type II, African Americans, Blacks, Non-Hispanic Blacks, Randomized Control Trial, Controlled Clinical Trial, Behavioral Research, Behavioral Medicine

Brief summary

The purpose of this project is two-fold: (1) to determine the feasibility of recruiting rural African American (AA) adults in South Carolina (SC) for assessing the usefulness of tablet-based resources in good diabetes self-management behaviors, and (2) to test a tablet-aided intervention for improving diabetes self-management behaviors

Detailed description

The proposed study will assess the feasibility of recruitment of African American adults residing in rural South Carolina who will assist with improving the usability of tablet computers. In addition, we will implement a pilot trial of the TABLETS (Tablet-Aided BehavioraL intervention Effect on Self-management skills) intervention for diabetes, using motivational strategies, among rural African Americans. The proposed project is designed to address 3 important issues: recruitment for a hard-to-reach population, utility of technology-enabled intervention, and development of a tablet-aided intervention tailored to understand best practices for diabetes self-management

Interventions

BEHAVIORALTablets Intervention

The TABLET intervention adds a novel tablet-based delivery mechanism to provide real-time videoconferencing education about diabetes self-management behaviors to high-risk, low-income African American (AA) adults with diabetes. Cardiovascular disease (CVD) knowledge/ information modules consist of materials developed from a CVD patient education booklet adapted from Maine Heart Center of Maine Health and supplemented by clinical guidelines to specifically address behavioral risk factors. Motivation/behavioral skills training modules consist of patient activation (asking questions to providers), patient empowerment (CVD responsibility contracts, flow charts for lab results), and behavioral skills training (self-monitoring, goal-setting).

Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
45 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Age ≥45 years * Clinical diagnosis of diabetes with HbA1c ≥8% and either diagnosis of hyperlipidemia with LDL \>100mg/dL or hypertension with BP \>140/80mmHg * Self-identified as African American * Residence in a 4G cellular service area * Able to communicate in English

Exclusion criteria

* Cognitive impairment * Active alcohol or drug abuse/dependency * Acute decompensation of chronic conditions precluding participation * Participation in other diabetes clinical trials * A life expectancy \<6 months

Design outcomes

Primary

MeasureTime frameDescription
Self-Monitoring Behavior Using the Summary of Diabetes Self-Care Activities6 months post-randomizationThis will be done to assess self-management behaviors for diabetes.
Physical Activity Score on the Global Physical Activity Questionnaire6 months post-randomizationInformation will be collected to assess physical activity in three domains and sedentary behaviors.
Medication Adherence on the Morisky Medication Adherence Scale6 months post-randomizationScale will be used to assess specific medication-taking behaviors.
Diet Score on the Rapid Eating and Activity Assessment for Participants6 months post-randomizationDietary intake will be assessed.

Secondary

MeasureTime frameDescription
Glycosylated Hemoglobin A1c (HbA1c)6 months post-randomizationBlood specimens (10cc of blood) will be obtained at baseline, 2, and 6-month visits for HbA1c.
Quality of Life Using the Medical Outcomes Study Short Form6 months post-randomizationWe will obtain summary physical and mental health quality of life scores.
Low-Density Lipoprotein Cholesterol (LDL-c)6 months post-randomizationBlood specimens (10cc of blood) will be obtained at baseline, 2, and 6-month visits for non-fasting lipids.
Blood Pressure6 months post-randomizationBlood pressure (BP) readings will be obtained using automated BP monitors. The device will be programmed to take 3 readings at 2 minute intervals, and give an average of the 3 BP readings.
Cardiovascular Disease (CVD) Risk Using the Framingham Risk Score6 months post-randomizationThis score will be used to estimate the 10-year risk for coronary heart disease outcomes (i.e., heart attack, death) according to 7 factors (age, gender, total cholesterol, high-density lipoprotein cholesterol, systolic blood pressure, high blood pressure medication use, and smoking status).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026